Bleeding risk with ischemic stroke therapy - Reply

dc.contributor.author	Xian, Y
dc.contributor.author	Liang, L
dc.contributor.author	Peterson, ED
dc.date.accessioned	2020-10-27T18:05:58Z
dc.date.available	2020-10-27T18:05:58Z
dc.date.issued	2012-10-03
dc.date.updated	2020-10-27T18:05:58Z
dc.identifier.issn	0098-7484
dc.identifier.issn	1538-3598
dc.identifier.uri	https://hdl.handle.net/10161/21643
dc.language	en
dc.publisher	American Medical Association (AMA)
dc.relation.ispartof	JAMA - Journal of the American Medical Association
dc.relation.isversionof	10.1001/2012.jama.11667
dc.subject	Science & Technology
dc.subject	Life Sciences & Biomedicine
dc.subject	Medicine, General & Internal
dc.subject	General & Internal Medicine
dc.subject	TISSUE-PLASMINOGEN ACTIVATOR
dc.subject	INTRACEREBRAL HEMORRHAGE
dc.subject	THROMBOLYSIS
dc.title	Bleeding risk with ischemic stroke therapy - Reply
dc.type	Journal article
duke.contributor.orcid	Xian, Y\|0000-0002-1237-1162
duke.contributor.orcid	Peterson, ED\|0000-0002-5415-4721
pubs.begin-page	1319
pubs.end-page	1320
pubs.issue	13
pubs.organisational-group	School of Medicine
pubs.organisational-group	Duke Clinical Research Institute
pubs.organisational-group	Medicine, Cardiology
pubs.organisational-group	Duke
pubs.organisational-group	Institutes and Centers
pubs.organisational-group	Medicine
pubs.organisational-group	Clinical Science Departments
pubs.organisational-group	Neurology, Neurocritical Care
pubs.organisational-group	Medicine, Clinical Pharmacology
pubs.organisational-group	Neurology
pubs.publication-status	Published
pubs.volume	308

Files

Now showing 1 - 1 of 1